Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4451
Ribbon Communications
RBBN
$363M
| $514K | ﹤0.01% |
184,251
-1,380,030
| -88% | -$3.83M |
|
|
AMLI
4452
DELISTED
American Lithium Corp. Common Stock
AMLI
| $514K | ﹤0.01% |
255,777
+113,965
| +80% | +$239K |
|
4453
iShares US Healthcare Providers ETF
IHF
$1.23B
| $514K | ﹤0.01% |
+10,040
| New | +$508K |
|
4454
Neuronetics
STIM
$224M
| $513K | ﹤0.01% |
238,732
-70,679
| -23% | -$171K |
|
4455
CALL
DoorDash
DASH
$103B
| $512K | ﹤0.01% |
6,700
| – | – |
|
4456
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
| $511K | ﹤0.01% |
10,188
-66,473
| -87% | -$3.35M |
|
|
DFP
4457
Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP
$422M
| $510K | ﹤0.01% |
+29,285
| New | +$513K |
|
|
ASLN
4458
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $510K | ﹤0.01% |
17,455
-6,152
| -26% | -$190K |
|
4459
Construction Partners
ROAD
$6.25B
| $509K | ﹤0.01% |
16,228
+7,051
| +77% | +$202K |
|
4460
Blue Ridge Bankshares
BRBS
$352M
| $508K | ﹤0.01% |
57,409
-19,072
| -25% | -$173K |
|
4461
MediciNova
MNOV
$70.9M
| $508K | ﹤0.01% |
220,706
-31,235
| -12% | -$68.8K |
|
4462
Dime Commercial Bancshares
DCOM
$1.79B
| $507K | ﹤0.01% |
28,753
+18,073
| +169% | +$336K |
|
4463
Woodside Energy
WDS
$43.8B
| $507K | ﹤0.01% |
+21,852
| New | +$501K |
|
4464
KB Financial Group
KB
$43.6B
| $506K | ﹤0.01% |
+13,914
| New | +$513K |
|
4465
CALL
Teladoc Health
TDOC
$1.18B
| $506K | ﹤0.01% |
+20,000
| New | +$503K |
|
4466
Neurogene
NGNE
$732M
| $506K | ﹤0.01% |
30,483
-8,374
| -22% | -$137K |
|
4467
Matrix Service
MTRX
$305M
| $506K | ﹤0.01% |
85,890
-110,127
| -56% | -$602K |
|
4468
OP Bancorp
OPBK
$226M
| $505K | ﹤0.01% |
59,867
+1,886
| +3% | +$16K |
|
|
CWAN
4469
DELISTED
Clearwater Analytics
CWAN
| $505K | ﹤0.01% |
31,793
-34,371
| -52% | -$543K |
|
4470
Hippo Holdings
HIPO
$876M
| $504K | ﹤0.01% |
+30,485
| New | +$529K |
|
4471
Bankwell Financial Group
BWFG
$531M
| $504K | ﹤0.01% |
20,654
-13,816
| -40% | -$328K |
|
4472
Liberty Latin America Class C
LILAK
$1.66B
| $504K | ﹤0.01% |
+64,253
| New | +$479K |
|
4473
PUT
ARS Pharmaceuticals
SPRY
$586M
| $503K | ﹤0.01% |
+75,000
| New | +$501K |
|
4474
PUT
Keysight
KEYS
$54.5B
| $502K | ﹤0.01% |
3,000
-42,200
| -93% | -$6.55M |
|
|
FL
4475
CALL
DELISTED
Foot Locker
FL
| $502K | ﹤0.01% |
18,500
+2,300
| +14% | +$78.3K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.